Effect of Azithromycin on preterm babies who are on ventilator

Effect of Azithromycin on Mortality in Mechanical Ventilated preterm babies â?? A Randomized Control Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048582

Enrollment

Registered

2022-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P220- Respiratory distress syndrome of newborn

Interventions

Intervention1: Injection Azithromycin: Injection Azithromycin is administered at adose of 10mg/kg/day single dose for 5 days Control Intervention1: Normal Saline: 2 ml of saline is given iv once a day

Eligibility

Inclusion criteria

Inclusion criteria: Mechanically ventilated preterm neonates(Gestational age less than 37weeks)

Exclusion criteria

Exclusion criteria: Babies with congenital malformations

Design outcomes

Primary

Measure	Time frame
The risk reduction of mortality in the intervention group will be calculatedTimepoint: at the time of discharge/DAMA/Death	—

Secondary

Measure	Time frame
Duration of VentilationTimepoint: At the time of discharge;Incidence of PDA/NEC/Sepsis/IVHTimepoint: During Hospital stay;Total duration of hospital stayTimepoint: At the time of discharge;Total duration of respiratory supportTimepoint: At the time of discharge	—

Countries

India

Contacts

Public ContactDr Sushma Krishnegowda

JSS Academy of Higher Education and Research

drsushmasri@gmail.com08212335333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026